Identification of post-mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration.
about
A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patientsProteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects.Recent cerebrospinal fluid biomarker studies of Alzheimer's disease.Application of proteomics to cerebrovascular disease.Biomarkers: mining the biofluid proteome.Blood glutathione S-transferase-π as a time indicator of stroke onsetYear in review in Intensive Care Medicine 2010: I. Acute renal failure, outcome, risk assessment and ICU performance, sepsis, neuro intensive care and experimentalsProliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.The "Alzheimer's disease signature": potential perspectives for novel biomarkers.Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.CSF proteome: a protein repository for potential biomarker identification.The Clinical Relevance of Serum NDKA, NMDA, PARK7, and UFDP Levels with Phlegm-Heat Syndrome and Treatment Efficacy Evaluation of Traditional Chinese Medicine in Acute Ischemic StrokeDetection of brain injury by fatty acid-binding proteins.H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury.Two-dimensional protein electrophoresis: from molecular pathway discovery to biomarker discovery in neurological disorders.Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects.Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker?The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients.Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic strokeRole of Glutathione-S-transferases in neurological problems.Extracellular NME proteins: a player or a bystander?Proteomic Analysis of Brain and Cerebrospinal Fluid from the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Potential Biomarkers.Characterization of mature rat oligodendrocytes: a proteomic approach.
P2860
Q33474338-286C7951-2230-4469-B855-181ACD14578EQ33666765-1617BB3D-DC4F-4A41-B50F-552111787CE6Q33691896-7E8FAF0A-5F04-4628-882F-0F2837EAFA31Q33766323-5DB3C298-A5A6-47EB-A78E-01A424513BF1Q34312457-2D051130-641E-4E33-9F10-43ADEB6EC559Q34389937-773F1BBD-2A93-42AC-8780-803F1ABAE262Q34426843-3C1D0562-2833-4E32-A0F5-F9DBD5EDC420Q34534501-8342509D-8CBF-48B8-8A80-C9EBE8D6A2ADQ35126686-D5774C30-DA64-446C-8EDD-391A0A591D20Q35339326-20855689-8DEC-46EC-B485-BA8F23A82E8FQ36121377-6721566D-CA5C-44EF-9488-F2EA92717260Q36168470-019A8B02-5785-4884-9BA0-A59E758CF562Q36204356-C72067C1-AC75-4B28-BE4A-756CFBE4AAF5Q36275438-615DACFB-3B0E-4A44-9CDB-A6387001AD5CQ36349690-5FCC0E0D-B64B-41E2-9A2A-9F9DD5F22BD0Q36525162-A450C130-AE1B-4CC1-A33B-A6B1EEA54CDEQ36925296-EEE83B57-4E9E-47F2-AB37-37825BE7AFA4Q37118083-B0E13781-A63C-486E-A69E-740CFB0E0C8EQ37166782-5B0B45F2-D776-465C-AF9C-CFA0BF93DBF6Q37280979-14E4BE35-2178-4663-82E7-80A73DFEF681Q38992254-876C6F37-4EA9-4689-83BA-111CE53C200BQ47648708-D4A9B765-1A64-47AA-B972-43F60D6E117FQ47973239-B111126F-0818-4B3B-876C-12CDBBB45968Q48198699-7CFC6A18-FB83-49B6-AB9C-28EC607303F2
P2860
Identification of post-mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Identification of post-mortem ...... schemia and neurodegeneration.
@ast
Identification of post-mortem ...... schemia and neurodegeneration.
@en
Identification of post-mortem ...... schemia and neurodegeneration.
@nl
type
label
Identification of post-mortem ...... schemia and neurodegeneration.
@ast
Identification of post-mortem ...... schemia and neurodegeneration.
@en
Identification of post-mortem ...... schemia and neurodegeneration.
@nl
prefLabel
Identification of post-mortem ...... schemia and neurodegeneration.
@ast
Identification of post-mortem ...... schemia and neurodegeneration.
@en
Identification of post-mortem ...... schemia and neurodegeneration.
@nl
P2093
P356
P1433
P1476
Identification of post-mortem ...... ischemia and neurodegeneration
@en
P2093
Catherine G Zimmermann-Ivol
Denis F Hochstrasser
Jean-Charles Sanchez
Jennifer A Burgess
Laure Allard
Pierre R Burkhard
Séverine Hughes-Frutiger
P304
P356
10.1002/PMIC.200300822
P577
2004-08-01T00:00:00Z